Secondary outcomes , assessed at 4 and 12 months of age , included ARI hospitalization rates and mothers ' report of infants ' SHS exposure ( validated by urinary cotinine/creatinine ratios [ CCRs ] ) , smoking restrictions , and smoking cessation .